Black Women, Uninsured Get Worse Ovarian Cancer Care:
TUESDAY, March 27 (HealthDay News) -- Women with ovarian cancer
who are black, either uninsured or Medicare recipients, or who have
annual incomes of less than $35,000 are more likely to receive
poorer-quality care, a new study shows.
Researchers found these racial and socioeconomic disparities in
ovarian cancer care also are associated with worse odds of
surviving for five years after their cancer diagnosis.
The study examined more than 47,000 women treated for ovarian
cancer between 1998 and 2002. Fewer than half of the women (44
percent) received treatment that fit within guidelines developed by
a group of the top cancer centers in the world and recommended by
the National Comprehensive Cancer Network.
Black women, women who were uninsured or on Medicare and women
of lower socioeconomic status were less likely than other women to
receive the recommended treatment.
But researchers noted racial disparities even among women who
did receive the recommended care. Black women's five-year survival
rate was 33 percent, compared to 41 percent among white women.
The study's authors said more research is needed to determine
why black women have different outcomes even when they receive the
same level of care.
The study was scheduled to be presented Tuesday during the
Society of Gynecologic Oncology annual meeting in Austin,
Because this study was presented at a medical meeting, the data
and conclusions should be viewed as preliminary until published in
a peer-reviewed journal.
The U.S. National Conference of State Legislatures provides more
disparities in health care.
Copyright © 2012
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.